The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
Open accessAbstract
BACKGROUND: Catheter ablation of atrial fibrillation is typically performed with uninterrupted anticoagulation with warfarin or interrupted non-vitamin K antagonist oral anticoagulant therapy. Uninterrupted anticoagulation with a non-vitamin K antagonist oral anticoagulant, such as dabigatran, may be safer; however, controlled data are lacking. We investigated the safety of uninterrupted dabigatran versus warfarin in patients undergoing ablation of atrial fibrillation. METHODS: In this randomized, open-label, multicenter, controlled trial with blinded adjudicated end-point assessments, we randomly assigned patients scheduled for catheter ablation of paroxysmal or persistent atrial fibrillation to receive either dabigatran (150 mg twice daily) or warfarin (target international normalized ratio, 2.0 to 3.0). Ablation was performed after 4 to 8 weeks of uninterrupted anticoagulation, which was continued during and for 8 weeks after ablation. The primary end point was the incidence of major bleeding events during and up to 8 weeks after ablation; secondary end points included thromboembolic and other bleeding events. RESULTS: The trial enrolled 704 patients across 104 sites; 635 patients underwent ablation. Baseline characteristics were balanced between treatment groups. The incidence of major bleeding events during and up to 8 weeks after ablation was lower with dabigatran than with warfarin (5 patients [1.6%] vs. 22 patients [6.9%]; absolute risk difference, -5.3 percentage points; 95% confidence interval, -8.4 to -2.2; P<0.001). Dabigatran was associated with fewer periprocedural pericardial tamponades and groin hematomas than warfarin. The two treatment groups had a similar incidence of minor bleeding events. One thromboembolic event occurred in the warfarin group. CONCLUSIONS: In patients undergoing ablation for atrial fibrillation, anticoagulation with uninterrupted dabigatran was associated with fewer bleeding complications than uninterrupted warfarin. (Funded by Boehringer Ingelheim; RE-CIRCUIT ClinicalTrials.gov number, NCT02348723 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citationSCHULMAN, S., & KEARON, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01204.x · Cited by 5,009
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Self-citationCalkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Europace · doi:10.1093/europace/eus027 · Cited by 2,722
Self-citationA Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,065
Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., Yang, S., Alings, M., Kaatz, S., Hohnloser, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004747 · Cited by 1,081
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2013) · Europace · doi:10.1093/europace/eut083 · Cited by 792
Graham, D. J., Reichman, M. E., Wernecke, M., Zhang, R., Southworth, M. R., Levenson, M., Sheu, T.-C., Mott, K., Goulding, M. R., Houstoun, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012061 · Cited by 644
Di Biase, L., Burkhardt, J. D., Santangeli, P., Mohanty, P., Sanchez, J. E., Horton, R., Gallinghouse, G. J., Themistoclakis, S., Rossillo, A., Lakkireddy, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006426 · Cited by 485
Larsen, T. B., Skjøth, F., Nielsen, P. B., Kjældgaard, J. N., & Lip, G. Y. H. (2016) · BMJ · doi:10.1136/bmj.i3189 · Cited by 441
Cappato, R., Marchlinski, F. E., Hohnloser, S. H., Naccarelli, G. V., Xiang, J., Wilber, D. J., Ma, C.-S., Hess, S., Wells, D. S., Juang, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv177 · Cited by 422
Self-citationYao, X., Abraham, N. S., Sangaralingham, L. R., Bellolio, M. F., McBane, R. D., Shah, N. D., & Noseworthy, P. A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003725 · Cited by 419
Larsen, T. B., Rasmussen, L. H., Skjøth, F., Due, K. M., Callréus, T., Rosenzweig, M., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.020 · Cited by 403
Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vanga, S. R., Santangeli, P., Swarup, V., Pimentel, R., Mansour, M. C., D'Avila, A., Sanchez, J. E., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.014 · Cited by 356
Graham, D. J., Reichman, M. E., Wernecke, M., Hsueh, Y.-H., Izem, R., Southworth, M. R., Wei, Y., Liao, J., Goulding, M. R., Mott, K., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.5954 · Cited by 312
Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vallakati, A., Mansour, M. C., Santangeli, P., Gangireddy, S., Swarup, V., Chalhoub, F., Atkins, D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.039 · Cited by 177
Self-citationBassiouny, M., Saliba, W., Rickard, J., Shao, M., Sey, A., Diab, M., Martin, D. O., Hussein, A., Khoury, M., Abi-Saleh, B., et al. (2013) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000320 · Cited by 164
Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation
Kim, J. S., She, F., Jongnarangsin, K., Chugh, A., Latchamsetty, R., Ghanbari, H., Crawford, T. C., Suwanagool, A., Sinno, M., Carrigan, T., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.12.011 · Cited by 146
Maddox, W. R., Kay, G. N., Yamada, T., Osorio, J., Doppalapudi, H., Plumb, V. J., Gunter, A., & McElderry, H. T. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12143 · Cited by 94
Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice
Romanelli, R. J., Nolting, L., Dolginsky, M., Kym, E., & Orrico, K. B. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002369 · Cited by 92
NIN, T., Sairaku, A., Yoshida, Y., Kamiya, H., Tatematsu, Y., Nanasato, M., Inden, Y., Hirayama, H., & Murohara, T. (2012) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12036 · Cited by 79
Armbruster, H., Lindsley, J. P., Moranville, M. P., et al. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014563950 · Cited by 67
Wu, S., Yang, Y., Zhu, J., Wan, H., Wang, J., Zhang, H., & Shao, X. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.12.027 · Cited by 61
Yamaji, H., Murakami, T., Hina, K., Higashiya, S., Kawamura, H., Murakami, M., Kamikawa, S., Hirohata, S., & Kusachi, S. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-013-0081-1 · Cited by 55
Page, S. P., SIDDIQUI, M. S., Finlay, M., Hunter, R. J., Abrams, D. J., Dhinoja, M., Earley, M. J., Sporton, S. C., & SCHILLING, R. J. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01910.x · Cited by 54
Self-citationAryal, M. R., Ukaigwe, A., Pandit, A., Karmacharya, P., Pradhan, R., Mainali, N. R., Pathak, R., Jalota, L., Bhandari, Y., & Donato, A. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.05.038 · Cited by 47
Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation
Stepanyan, G., Badhwar, N., Lee, R. J., Marcus, G. M., Lee, B. K., Tseng, Z. H., Vedantham, V., Olgin, J. E., Scheinman, M. M., & Gerstenfeld, E. P. (2014) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-014-9888-9 · Cited by 44
Self-citationKaiser, D. W., Streur, M. M., Nagarakanti, R., Whalen, S. P., & Ellis, C. R. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9793-7 · Cited by 42
Sardar, P., Nairooz, R. S., Chatterjee, S., Wetterslev, J., Ghosh, J., & Aronow, W. S. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.12.027 · Cited by 39
Arshad, A., Johnson, C. K., Mittal, S., Buch, E. F., Hamam, I. R. T., Tran, T., Shaw, R. E., Musat, D. L., Preminger, M. W., Sichrovsky, T., et al. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12401 · Cited by 36
Nagao, T., Inden, Y., Shimano, M., Fujita, M., Yanagisawa, S., Kato, H., Ishikawa, S., Miyoshi, A., Okumura, S., Ohguchi, S., et al. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.3520 · Cited by 30
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 2,765
Calkins, H., Hindricks, G., Cappato, R., Kim, Y.-H., Saad, E. B., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,755
Self-citationJanuary, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000665 · Cited by 2,744
Self-citationJanuary, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.011 · Cited by 2,205
Self-citation
Metadata
- Authors
- Calkins, H., Willems, S., Gerstenfeld, E. P., Verma, A., Schilling, R., Hohnloser, S. H., Okumura, K., Serota, H., Nordaby, M., Guiver, K., Biss, B., Brouwer, M. A., & Grimaldi, M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-04-27
- Volume
- 376
- Issue
- 17
- Pages
- 1627-1636
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2595627091
- Cited by
- 430
- References
- 33
- FWCI
- 45.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.